Moleculin Biotech, Inc. – COMMON STOCK PURCHASE WARRANT Moleculin Biotech, Inc. (June 21st, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December __, 2018 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on December ___, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Moleculin Biotech, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Placement Agents Common Stock Purchase Warrant Reshape Lifesciences Inc. (June 21st, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the Initial Exercise Date) and on or prior to 5:00 p.m. (New York City time) on June 19, 2023 (the Termination Date) but not thereafter, to subscribe for and purchase from ReShape Lifesciences Inc., a Delaware corporation (the Company), up to shares (as subject to adjustment hereunder, the Warrant Shares) of the Companys common stock (the Common Stock). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of May 8, 2018, by and between the Company and H.C. Wainwright & Co., LLC.

Integrated Surg Sys – Common Stock Purchase Warrant Themaven, Inc. (June 21st, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received in the form of the surrender of certain existent rights for additional shares of Common Stock (as defined below) of theMaven, Inc., a Delaware corporation, (the "Company") under two securities purchase agreements dated January 4, 2018 and March 30, 2018, Strome Mezzanine Fund LP (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof during the Exercise Period (as defined below), to purchase from the Company, up to 1,500,000 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price (defined below) per share then in effect.

Common Stock Purchase Warrant Reshape Lifesciences Inc. (June 21st, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the Initial Exercise Date) and on or prior to 5:00 p.m. (New York City time) on (1) (the Termination Date) but not thereafter, to subscribe for and purchase from ReShape Lifesciences Inc., a Delaware corporation (the Company), up to shares (as subject to adjustment hereunder, the Warrant Shares) of the Companys common stock (the Common Stock). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SONUS Pharmaceuticals, Inc. – Common Stock Purchase Warrant Achieve Life Sciences, Inc. (June 20th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, CEDE & CO. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on June 19, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Achieve Life Sciences, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, subject to a Holder'

Soligenix Inc. – Common Stock Purchase Warrant Soligenix, Inc. (June 20th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, ____________________ or [his][her][its] assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the Expiration Date (as defined in Section 2(b) below) but not thereafter, to subscribe for and purchase from Soligenix, Inc., a Delaware corporation (the "Company"), up to ___________ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(a).

Social Reality Inc. Class a Common Stock Purchase Warrant (June 19th, 2018)

This certifies that, for good and valuable consideration, receipt of which is hereby acknowledged, [*] (Holder) is entitled to purchase, subject to the terms and conditions of this Warrant, from Social Reality Inc., a Delaware corporation (the Company), __________ ([*]) fully paid and nonassessable shares of the Companys Class A Common Stock, par value $0.001 per share (Class A Common). Holder shall be entitled to purchase the shares of Class A Common in accordance with Section 2 at any time subsequent to the date of this Warrant set forth above and prior to the Expiration Date (as defined below). The shares of Class A Common of the Company for which this Warrant is exercisable, as adjusted from time to time pursuant to the terms hereof, are hereinafter referred to as the Shares. This Warrant is issued to the Holder at the direction of Market Street Investor Relations, LLC (the "Consultant") and was part of the compensation to the Consultant pursuant to the terms and conditions of t

Common Stock Purchase Warrant Ipass Inc. (June 19th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Issue Date") and on or prior to 6:30 p.m., New York City time, on the seven (7)-year anniversary of the Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from iPASS Inc., a Delaware corporation (the "Company"), up to _____ shares (as adjusted from time to time as provided in Section 3) of common stock, par value $0.001 per share, of the Company (the "Common Stock"). Each such share is referred to herein as a "Warrant Share" and all such shares, the "Warrant Shares". The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2.2.

Common Stock Purchase Warrant Compugen Ltd. (June 19th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (this "Warrant") certifies that, for value received, [_______] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December 19, 2018 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on June 19, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from COMPUGEN LTD., a corporation organized under the laws of the State of Israel (the "Company"), up to [______] shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Freight Solution Inc – Common Stock Purchase Warrant (June 18th, 2018)

Freight Solution, Inc., a corporation organized under the laws of the State of Nevada (the "Company"), hereby certifies that, for value received, or its assigns [_________________] (the "Holder"), is entitled, subject to the terms and limitations on exercise and conditions hereinafter set fifth below, to purchase from the Company at any time after the Issue Date until 5:00 p.m., E.S.T on the fourth anniversary of the Issue Date (the "Termination Date"), up to 1,500,000 fully paid and nonassessable shares of Common Stock at a per share purchase price of $0.30 (the "Exercise Price"). The number and character of such shares of Common Stock and the Exercise Price are subject to adjustment as provided herein. The Company may reduce the Exercise Price for some or all of the Warrants, temporarily or permanently, provided such reduction is made as to all outstanding Warrants for all Holders of such Warrants.

Greater Cannabis Company, Inc. – Common Stock Purchase Warrant the Greater Cannabis Company, Inc. (June 15th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, EMET CAPITAL PARTNERS LLC, 395 Pearsall Avenue, Unit D, Cedarhurst, NY 11516 Fax: (727) 547-7350, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the sixty month anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from THE GREATER CANNABIS COMPANY, INC., a Florida corporation (the "Company"), up to 11,000 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Pressure BioSciences, Inc. – Common Stock Purchase Warrant Pressure Biosciences, Inc. (June 15th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, [HOLDER] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [Month Day, 2018] (the "Initial Exercise Date") and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Pressure BioSciences, Inc., a Massachusetts corporation (the "Company"), up to [xxxxxxx] shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Series B Pre-Funded Common Stock Purchase Warrant Invivo Therapeutics Holdings Corp. (June 14th, 2018)

THIS SERIES B PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, CEDE & CO. or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the Initial Exercise Date) and on or prior to 5:00 p.m. (New York City time) on (1) (the Termination Date) but not thereafter, to subscribe for and purchase from InVivo Therapeutics Holdings Corp., a Nevada corporation (the Company), up to shares (as subject to adjustment hereunder, the Warrant Shares) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (DTC) shall initially be the sole registered holder of this Warrant, subject to a Hol

Arcadia Biosciences – Common Stock Purchase Warrant (June 14th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on ______________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Arcadia Biosciences, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Series a Common Stock Purchase Warrant Invivo Therapeutics Holdings Corp. (June 14th, 2018)

THIS SERIES A COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, CEDE & CO. or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the Initial Exercise Date) and on or prior to 5:00 p.m. (New York City time) on (1) (the Termination Date) but not thereafter, to subscribe for and purchase from InVivo Therapeutics Holdings Corp., a Nevada corporation (the Company), up to shares (as subject to adjustment hereunder, the Warrant Shares) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (DTC) shall initially be the sole registered holder of this Warrant, subject to a Holders right

Arcadia Biosciences – Placement Agent Common Stock Purchase Warrant (June 14th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on June 12, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Arcadia Biosciences, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of June 10, 2018.

Sorrento Therapeutics, Inc. – Common Stock Purchase Warrant Sorrento Therapeutics, Inc. (June 14th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (this "Warrant") certifies that, for value received, ___________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time and from time to time on or after December 11, 2018 (the "Initial Exercise Date") and on or prior to the close of business on December 13, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Sorrento Therapeutics, Inc., a Delaware corporation (the "Company"), up to ___________shares of Common Stock (subject to the limitation in Section 2(e) and as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price (as defined below).

Integrated Surg Sys – Common Stock Purchase Warrant Themaven, Inc. (June 12th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the funding of the purchase price of $500,000.00, with respect to the first tranche of $570,555.720 issuance of that certain convertible promissory note in the original principal amount of $1,681,668.00 on June 6, 2018 by the Company (as defined below) to the Holder (as defined below)) (the "Note"), L2 Capital, LLC, a Kansas limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from TheMaven, Inc., a Delaware corporation (the "Company"), up to 216,120 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) (with the understanding that the Holder shall only

Trovagene Inc – Common Stock Purchase Warrant Trovagene, Inc. (June 12th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 12, 2018 (the Initial Exercise Date) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the Termination Date) but not thereafter, to subscribe for and purchase from Trovagene, Inc., a Delaware corporation (the Company), up to shares (as subject to adjustment hereunder, the Warrant Shares) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SONUS Pharmaceuticals, Inc. – Common Stock Purchase Warrant Achieve Life Sciences, Inc. (June 12th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, CEDE & CO. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on _____ __, 20231 (the "Termination Date") but not thereafter, to subscribe for and purchase from Achieve Life Sciences, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, subject to a Holde

Adial Pharmaceuticals, L.L.C. – [Form of Certificated Warrant] Common Stock Purchase Warrant Adial Pharmaceuticals, Inc. (June 11th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [*], 2018 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Adial Pharmaceuticals, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered hol

Common Stock Purchase Warrant Reshape Lifesciences Inc. (June 8th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the Initial Exercise Date) and on or prior to 5:00 p.m. (New York City time) on (1) (the Termination Date) but not thereafter, to subscribe for and purchase from ReShape Lifesciences Inc., a Delaware corporation (the Company), up to shares (as subject to adjustment hereunder, the Warrant Shares) of the Companys common stock (the Common Stock). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

ShiftPixy, Inc. – Common Stock Purchase Warrant Shiftpixy, Inc. (June 8th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, ________, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December 4, 2018 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on December 4, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from ShiftPixy, Inc., a Wyoming corporation (the "Company"), up to 251,004 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Placement Agents Common Stock Purchase Warrant Reshape Lifesciences Inc. (June 8th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the Initial Exercise Date) and on or prior to 5:00 p.m. (New York City time) on June 7, 2023 (the Termination Date) but not thereafter, to subscribe for and purchase from ReShape Lifesciences Inc., a Delaware corporation (the Company), up to shares (as subject to adjustment hereunder, the Warrant Shares) of the Companys common stock (the Common Stock). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of May 8, 2018, by and between the Company and H.C. Wainwright & Co., LLC.

Minn Shares Inc – EVO Transportation & Energy Services, Inc., a Delaware Corporation COMMON STOCK PURCHASE WARRANT (June 7th, 2018)

This Common Stock Purchase Warrant (this "Warrant") certifies that, for value received, the Warrant Holder named above is entitled to purchase from EVO Transportation & Energy Services, Inc., a Delaware corporation (the "Company"), during the period specified in this Warrant, Three Hundred Thirty-Three Thousand Three Hundred Thirty-Three (333,333) fully paid and non-assessable shares of Common Stock ("Warrant Stock"), at the purchase price per share provided in Section 1.2 of this Warrant (the "Warrant Exercise Price"), all subject to the terms and conditions set forth in this Warrant. Capitalized terms not otherwise defined shall have the meanings set forth in Section 5 below. This Warrant is issued in connection with that certain Equity Purchase Agreement by and between the Company and the Warrant Holder dated June 1, 2018 (the "Purchase Agreement").

Minn Shares Inc – EVO Transportation & Energy Services, Inc., a Delaware Corporation COMMON STOCK PURCHASE WARRANT (June 7th, 2018)

This Common Stock Purchase Warrant (this "Warrant") certifies that, for value received, the Warrant Holder named above is entitled to purchase from EVO Transportation & Energy Services, Inc., a Delaware corporation (the "Company"), during the period specified in this Warrant, Three Hundred Thirty-Three Thousand Three Hundred Thirty-Three (333,333) fully paid and non-assessable shares of Common Stock ("Warrant Stock"), at the purchase price per share provided in Section 1.2 of this Warrant (the "Warrant Exercise Price"), all subject to the terms and conditions set forth in this Warrant. Capitalized terms not otherwise defined shall have the meanings set forth in Section 5 below. This Warrant is issued in connection with that certain Equity Purchase Agreement by and between the Company and the Warrant Holder dated June 1, 2018 (the "Purchase Agreement").

Common Stock Purchase Warrant Brainstorm Cell Therapeutics Inc. (June 7th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as set forth above) and on or prior to the close of business on December 31, 2020 (the "Termination Date") but not thereafter, to subscribe for and purchase from Brainstorm Cell Therapeutics Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Minn Shares Inc – EVO Transportation & Energy Services, Inc., a Delaware Corporation COMMON STOCK PURCHASE WARRANT (June 7th, 2018)

This Common Stock Purchase Warrant (this "Warrant") certifies that, for value received, the Warrant Holder named above is entitled to purchase from EVO Transportation & Energy Services, Inc., a Delaware corporation (the "Company"), during the period specified in this Warrant, Three Hundred Thirty-Three Thousand Three Hundred Thirty-Three (333,333) fully paid and non-assessable shares of Common Stock ("Warrant Stock"), at the purchase price per share provided in Section 1.2 of this Warrant (the "Warrant Exercise Price"), all subject to the terms and conditions set forth in this Warrant. Capitalized terms not otherwise defined shall have the meanings set forth in Section 5 below. This Warrant is issued in connection with that certain Equity Purchase Agreement by and between the Company and the Warrant Holder dated June 1, 2018 (the "Purchase Agreement").

Common Stock Purchase Warrant (June 6th, 2018)

This warrant to purchase Common Stock ("Warrant") is issued in connection with and pursuant to that amendment dated May 31, 2018 to that certain Credit Agreement dated as of January 25, 2018 (the "Credit Agreement"), by and between the Company and Holder.

Electric Vehicle Research Corp – Common Stock Purchase Warrant Oncolix, Inc. (June 6th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________________________________, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Oncolix, Inc., a Florida corporation (the "Company"), up to _______________________________________________ shares of common stock, $0.0001 par value per share, of the Company (the "Common Stock") (subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Trovagene Inc – Common Stock Purchase Warrant Trovagene, Inc. (June 4th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, _____________ or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ________, 2018 (the Initial Exercise Date) and on or prior to the close of business on the ( ) year anniversary of the Initial Exercise Date (the Termination Date) but not thereafter, to subscribe for and purchase from Trovagene, Inc., a Delaware corporation (the Company), up to ______ shares (as subject to adjustment hereunder, the Warrant Shares) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

ContraVir Pharmaceuticals, Inc. – Series [ Common Stock Purchase Warrant Contravir Pharmaceuticals, Inc. (June 4th, 2018)

THIS SERIES [ COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the Initial Exercise Date) and on or prior to 5:00 p.m. (New York City time) on [ ](1) (the Termination Date) but not thereafter, to subscribe for and purchase from ContraVir Pharmaceuticals, Inc., a Delaware corporation (the Company), up to shares (as subject to adjustment hereunder, the Warrant Shares) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (DTC) shall initially be the sole registered holder of this Warrant, subject to a Holder

Heatwurx, Inc. – Common Stock Purchase Warrant Processa Pharmaceuticals, Inc. (June 1st, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, PoC Capital, LLC, a California limited liability company, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date and on or prior to 5:00 p.m. New York time on June 29, 2021 (the "Termination Date") but not thereafter, to subscribe for and purchase from Processa Pharmaceuticals, Inc., a Delaware corporation (the "Company"), up to 396,476 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Heatwurx, Inc. – Common Stock Purchase Warrant Processa Pharmaceuticals, Inc. (June 1st, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, PoC Capital, LLC, a California limited liability company, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date and on or prior to 5:00 p.m. New York time on June 29, 2021 (the "Termination Date") but not thereafter, to subscribe for and purchase from Processa Pharmaceuticals, Inc., a Delaware corporation (the "Company"), up to 198,238 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Veritone, Inc. – Common Stock Purchase Warrant Veritone, Inc. (June 1st, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, Veritone, Inc., a Delaware corporation (the Company), hereby grants to Acacia Research Corporation, a Delaware corporation (the Holder), subject to the terms and conditions set forth herein, the right to purchase up to a number of shares of common stock, par value $0.001 per share, of the Company (the Common Stock) equal to the quotient that results from dividing the Warrant Amount by the then applicable Exercise Price (as defined in Section 3(b)) (the Warrant Shares). The Warrant Amount means Seven Hundred Thousand Dollars ($700,000), as adjusted from to time to time pursuant to the terms and conditions hereof. At the time of any exercise of this Warrant in accordance with Section 3(a) (each, an Exercise), the purchase price of one (1) share of Common Stock under this Warrant shall be equal to the then applicable Exercise Price.